The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2025 | Unmet needs in LR-MDS: the need for strategies to treat anemia
Moshe Mittelman, MD, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, discusses the unmet needs in the treatment of patients with lower-risk myelodysplastic syndromes (MDS). He highlights that the majority of these patients are anemic and require transfusions, with current treatments having limited response rates and durations. This interview took place at the 67th ASH Annual Meeting and Exposition, held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
